T1	Participants 49 78	chronic hemodialysis patients
T2	Participants 239 299	14 chronic uremic patients on regular hemodialysis treatment
T3	Participants 513 621	Nine patients with chronic renal anemia on maintenance hemodialysis were enrolled in rHu-EPO treatment trial
